教授，博士生导师。主要研究方向 卫生经济、卫生政策、卫生技术评估、医院管理、老年保健。 学习经历 1978.10-1983.07 中国上海医科大学 公共卫生 本科 1983.09-1986.07 中国上海医科大学 公共卫生 硕士 1990.09-1991.10 英国里兹大学 卫生政策与管理 文学硕士 1991.10-1992.10 英国里兹大学 中国与亚洲研究 访问学者 1995.12-2000.01 瑞典卡尔琳斯卡医学院 国际卫生 博士 2000.06-2004.08 德国海徳堡大学 公共卫生 博士后 工作经历 1986.08-1988.07 中国上海医科大学公共卫生学院 助教 1988.07-1992.12 中国上海医科大学公共卫生学院 讲师 1992.12-1997.07 中国上海医科大学公共卫生学院 副教授 1997.07-2000.05 中国上海医科大学公共卫生学院 教授 1998.09-2000.04 中国上海医科大学公共卫生学院 院长助理 1998.01-2000.05 中国上海医科大学公共卫生学院 医院管理教研室主任 1998.01-2000.05 中国上海医科大学 卫生部卫生评估中心副主任 2000.06-2004.08 德国海徳堡大学公共卫生研究所 博士后、高级讲师 2004.08-2006.11 英国Brunel大学 卫生经济研究室 高级研究员 2006.12-2009.11 德国海徳堡大学公共卫生研究所 国际卫生经济与技术评估研究组主任 2009.11-目前 浙江大学医学部 卫生政策学研究中心主任、教授 出版著作 董恒进等，《公共卫生服务教学理论与方法》，人民卫生出版社，2015 董恒进等，《预防医学》，人民军医出版社，2016 董恒进等，《卫生监督与服务实践技能教程（公共卫生系列实践教材）》，浙江大学出版社，2013 董恒进等，《医院管理学》，复旦大学出版社，2002 Dong HJ. Chapter 11 in the book of Family Planning Statistics (Editor Gu XY).. Jiangsu Science and Technology Press. 1985. Dong HJ, Yan F. Planning for Health Human Resources. Shanghai Medical University Textbook. Shanghai, 1998. Dong HJ. One chapter in the book of Social Investigation Methodology. People's Health Press. Beijing, 1996. Dong HJ. One chapter in the book of Family Planning Statistics and Evaluation (Editor Gao ES). Chinese Population Press. Beijing, 1992. Dong HJ. One chapter in the book of Introduction on Centers for Disease Control (Editor Gong YL). Shanghai Science and Technology Press. Shanghai, 1991. Dong HJ. One chapter in the book of Evaluation on Rural Family Planning Program. Chinese Population Press (Editor Gao ES). Beijing, 1990. Dong HJ. Chapter 8 in the book of Population and Family Planning Statistics (Editor Gao ES). Nanjing University Press. Nanjing, 1989.

卫生经济 卫生技术评估 卫生政策 医院管理 老龄保健

国家紧密型县域医疗卫生共同体建设专家 CHS-DRG 国家技术指导组成员 中国卫生经济学会公共卫生经济专业委员会副主任委员 中国药学会药物经济学专业委员会委员 中国中药协会第三届药物经济学专业委员会委员 浙江省特聘专家 浙江省药学会药物经济学与卫生技术评估专业委员会主任委员 浙江省卫生经济学会卫生技术与药物经济学专业委员会主任委员

International peer-reviewed papers (published, in English) Gu, S., Shi, L., Shao, H. Hengjin Dong et al. Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis. BMC Med 18, 378 (2020). (IF 8.809) Zhao, Zixuan, Hengjin Dong, et al. Newborn Screening for Inherited Metabolic Diseases Using Tandem Mass Spectrometry in China: Outcome and Cost-Utility Analysis. Journal of Medical Screening, June 2021, doi:10.1177/09691413211021621. Zhen, X., Lundborg, C.S., Zhang, M. Hengjin Dong et al. Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China. Sci Rep 10, 3900 (2020). Gu, S., Wang, X., Shi, L. Hengjin Dong et al. Health-related quality of life of type 2 diabetes patients hospitalized for a diabetes-related complication. Qual Life Res 29, 2695–2704 (2020). https://doi.org/10.1007/s11136-020-02524-3 Zhen X, Stålsby Lundborg C, Sun X, Gu S, Dong H. Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by Klebsiella pneumonia, Pseudomonas aeruginosa, Acinetobacter baumannii: A Multicenter Study in China. Antibiotics. 2020; 9(8):514. Yuxuan, Gu, Hao, Hengjin Dong et al. Social Determinants of Health-Related Quality of Life among Residents in Zhejiang and Qinghai, China.[J]. International Journal of Environmental Research & Public Health, 2019. Xuemei Zhen, Yuanyuan Li, Yixi Chen, Peng Dong, Staphie Liu, Hengjin Dong. Effect of multiple drug resistance on total medical costs among patients with intraabdominal infections in China. PLoS ONE, 2018, 13 (3):1-12. DOI: https://doi.org/10.1371/journal.pone.0193977 Xuemei Zhen, Xueshan Sun, Hengjin Dong. Health Technology Assessment and its Use in Drug Policies in China. Value in Health Regional Issues, 2018, 15:138-148. DOI: https://doi.org/10.1016/j.vhri.2018.01.010 Xueshan Sun, Hao Zhang, Xiaoqian Hu, Shuyan Gu, Xuemei Zhen, Yuxuan Gu, Minzhuo Huang, Jingming Wei, Hengjin Dong. Measurement and analysis of equity in health a case study conducted in Zhejiang Province, China. International Journal for Equity in Health, 2018, 17(36):1-8. DOI: https://doi.org/10.1186/s12939-018-0746-8 Xuemei Zhen, Yixi Chen, Xiaoqian Hu, Peng Dong, Shuyan Gu, Young Yong Sheng, Hengjin Dong. The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province, China. European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36(10):1989-1994. DOI: https://doi.org/10.1007/s10096-017-3088-3 Shuyan Gu, Xiaoyong Wang, Qing Qiao, Weiguo Gao, Jian Wang, Hengjin Dong. Cost-Effectiveness of exenatide twice daily versus insulin glargine as add-on therapy to oral anti-diabetic agents in type 2 diabetes in China. Diabetes Obesity & Metabolism, 2017, 19, 1688-1697. DOI: 10.1111/dom.12991. Hai Gu, Hua You, Weiqing Ning, Hua Zhou, Jianming Wang, Ying Lu, Jun Sun, Yun Kou, Hengjin Dong. Internal migration and maternal health service utilisation in Jiangsu, China. Tropical Medicine & International Health, 2017, 22: 124-132. DOI: 10.1111/tmi.12806. Shuyan Gu, Yuhang Zeng, Demin Yu, Xiaoqian Hu, Hengjin Dong. Cost-Effectiveness of Saxagliptin versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China. PLoS ONE, 2016, 11: 1-21. DOI:10.1371/journal.pone.0167190. Shuyan Gu, Yiming Mu, Suodi Zhai, Yuhang Zeng, Xuemei Zhen, Hengjin Dong. Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China. PLoS ONE. 2016, 11(11): 1-25. doi:10.1371/journal.pone.0165629. Jianhua Chen, Hai Yu, Hengjin Dong. Effect of the new rural cooperative medical system on farmers' medical service needs and utilization in Ningbo, China. BMC Health Services Research. 2016, 16: 1-6. DOI: 10.1186/s12913-016-1842-3. Shuyan Gu, Huimei Hu, Hengjin Dong. Systematic Review of Health-Related Quality of Life in Patients with Pulmonary Arterial Hypertension. Pharmacoeconomics, 2016, 34: 751-770. DOI: 10.1007/s40273-016-0395-y. Hua You, Hai Gu, Weiqing Ning, Hua Zhou, Hengjin Dong. Comparing Maternal Services Utilization and Expense Reimbursement before and after the Adjustment of the New Rural Cooperative Medical Scheme Policy in Rural China, PLoS ONE, 2016, 11(7):1-10. DOI: 10.1371/journal.pone.0158473 Shuyan Gu, Huimei Hu, Hengjin Dong. Systematic Review of the Economic Burden of Pulmonary Arterial Hypertension. Pharmacoeconomics, 2016, 34: 533-550. DOI: 10.1007/s40273-015-0361-0 Christina Wu, Lin Gao, Shulin Chen & Hengjin Dong. Care services for elderly people with dementia in rural China: a case study. Bulletin of the World Health Organization, 2016, 94(3):167–173. DOI: 10.2471/BLT.15.160929 Shafiu Mohammed, Budi Aji, Justo Lorenzo Bermejo, Aurelia Solares, Hengjin Dong, and Rainer Sauerborn. User experience with a health insurance coverage and benefit-package access: implications for policy implementation towards expansion in Nigeria. Health Policy and Planning, 2016, 31(3): 346-355. doi: 10.1093/heapol/czv068. Hao Zhang, Huimei Hu, Christina Wu, Hai Yu, Hengjin Dong. Impact of China's Public Hospital Reform on Healthcare Expenditures and Utilization: A Case Study in ZJ Province. PLoS ONE, 2015, 10(11):1-19.doi:10.1371/journal.pone.0143130 . Yan Ding, Rainer Sauerborn, Biao Xu, Shaofa Nie, Weirong Yan, Vinod K.Diwan, Hengjin Dong. A cost-effectiveness analysis of three components of a syndromic surveillance system for the early warning of epidemics in rural China, BMC Public Health, 2015, 15:1-9. DOI: 10.1186/s12889-015-2475-x. Shuyan Gu, Jing Deng, Lizheng Shi, Yiming Mu, Hengjin Dong. Cost-effectiveness of saxagliptin vs glimepiride as a second-line therapy added to metformin in Type 2 diabetes in China. Journal of Medical Economics, 2015, 18(10): 808-820. doi:10.3111/13696998.2015.1049542. Yan Ding, Yang Fei, Biao Xu, Jun Yang, Weirong Yan, Vinod K. Diwan, Rainer Sauerborn and Hengjin Dong. Measuring costs of data collection at village clinics by village doctors for a syndromic surveillance system-a cross-sectional survey from China. BMC Health Services Research, 2015, 15(1):1-7. DOI 10.1186/s12913-015-0965-2. Shuyan Gu, ZhiliuTang, Lizheng Shi, Monika Sawhney, Huimei Hu, Hengjin Dong. Cost-Minimization Analysis of Metformin and Acarbose in Treatment of Type 2 Diabetes. Value in Health Regional Issues, 2015, 6: 84 – 88. DOI: https://doi.org/10.1016/j.vhri.2015.03.012 National peer-reviewed papers (published, in Chinese) 1. 董恒进. 提高医保基金绩效评价科学性需解决三大问题[J]. 中国医疗保险, 2020, No.144(09):40-41. 2. 孙雪姗,刘凯捷,甄雪梅,钱欣月,杨位,董恒进.公立医院改革对骨关节炎患者门诊次均费用的影响分析[J].中国卫生经济,2020,39(12):77-79. 3. 高奇隆,孙雪姗,魏景明,张永余,黄敏卓,董恒进.义乌市完善职工医保个人账户政策效果的评价研究——基于“投射—实施后”对比分析法[J].中国卫生政策研究,2019,12(10):8-14. 4. 董恒进、黄敏卓、吴韬. 健康中国视角下的医院发展探索. 中国医院, 2018, 1:1-2. 5. 黄敏卓、顾钰璇、魏景明、董恒进. 影响医患关系的社会与政策因素剖析. 中华医院管理, 2018, 2: 168-171. 6. 杨芊、於梦菲、王照品、董恒进. 免费定向医学生留任基层的教育激励研究. 医学教育研究与实践, 2017, 3: 342-344. 7. 张皓、杨芊、夏永鹏、赵江磊、陈丽锦、胡晓茜、李园园、黄敏卓、董恒进. 浙江省“百千万”卫生人才政策干预效果研究——基于系统动力学模型. 中国卫生政策研究. 2017, 5: 20-26. 8. 张皓、刘悦、顾淑燕、甄雪梅、曾玉航、顾钰璇、董恒进. 分级诊疗能节省成本吗?——基于系统动力学模型的浙江省诊疗系统分级优化成本测算. 中国卫生政策研究, 2017, 7:13-21. 9. 张皓、顾淑燕、杨芊、郜琳、甄雪梅、曾玉航、董恒进. 基于循证医学的我国基本药物目录遴选方法体系研究. 中华医院管理, 2017, 33(4):293-297. 10. 魏景明、顾钰璇、黄敏卓、宋琦琳、陈国忠、董恒进、戴慧芬. 浙江大学专科医联体实践与探索. 中华医院管理, 2017, 33(11):812-814.